![Bilastine Impurity A (Inhouse); 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | 202189-77-3](https://drjcrbio.com/wp-content/uploads/image_2021_08_28T08_37_48_338Z.png)
Bilastine Impurity A (Inhouse); 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | 202189-77-3
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole, Bilastine
Description
| Code: JCBST-09 |
| CAS: 202189-77-3 |
| Chemical Formula: C32H44N4O2 |
| Molecular Weight: 516.73 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Bilastine Impurity A (Inhouse); 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | 202189-77-3is useful as reference Impurity standard. |
